These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3474655)

  • 1. Transforming growth factor type beta specifically stimulates synthesis of proteoglycan in human adult arterial smooth muscle cells.
    Chen JK; Hoshi H; McKeehan WL
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5287-91. PubMed ID: 3474655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of human arterial smooth muscle cell chondroitin sulfate proteoglycan synthesis by transforming growth factor-beta.
    Chen JK; Hoshi H; McKeehan WL
    In Vitro Cell Dev Biol; 1991 Jan; 27(1):6-12. PubMed ID: 2013555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta 1 increases internalization of basic fibroblast growth factor by smooth muscle cells: implication of cell-surface heparan sulphate proteoglycan endocytosis.
    Berrou E; Quarck R; Fontenay-Roupie M; Lévy-Toledano S; Tobelem G; Bryckaert M
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):393-9. PubMed ID: 7487873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoglycans and vascular cell proliferation.
    Wight TN; Potter-Perigo S; Aulinskas T
    Am Rev Respir Dis; 1989 Oct; 140(4):1132-5. PubMed ID: 2508521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of platelet-derived growth factor and low density lipoproteins to glycosaminoglycan species produced by human arterial smooth muscle cells.
    Fager G; Camejo G; Olsson U; Ostergren-Lundén G; Lustig F; Bondjers G
    J Cell Physiol; 1995 May; 163(2):380-92. PubMed ID: 7706380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents.
    de Dios ST; Frontanilla KV; Nigro J; Ballinger ML; Ivey ME; Cawson EA; Little PJ
    J Diabetes Complications; 2007; 21(2):108-17. PubMed ID: 17331859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells.
    Schönherr E; Järveläinen HT; Sandell LJ; Wight TN
    J Biol Chem; 1991 Sep; 266(26):17640-7. PubMed ID: 1894644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells.
    Edwards IJ; Wagner WD; Owens RT
    Am J Pathol; 1990 Mar; 136(3):609-21. PubMed ID: 2316626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (S)-[6]-Gingerol inhibits TGF-β-stimulated biglycan synthesis but not glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
    Kamato D; Babaahmadi Rezaei H; Getachew R; Thach L; Guidone D; Osman N; Roufogalis B; Duke CC; Tran VH; Zheng W; Little PJ
    J Pharm Pharmacol; 2013 Jul; 65(7):1026-36. PubMed ID: 23738730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells.
    Getachew R; Ballinger ML; Burch ML; Little PJ; Osman N
    Eur J Pharmacol; 2010 Jan; 626(2-3):186-92. PubMed ID: 19818754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular cell proteoglycans: evidence for metabolic modulation.
    Wight TN; Kinsella MG; Lark MW; Potter-Perigo S
    Ciba Found Symp; 1986; 124():241-59. PubMed ID: 3816418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.
    McCaffrey TA; Consigli S; Du B; Falcone DJ; Sanborn TA; Spokojny AM; Bush HL
    J Clin Invest; 1995 Dec; 96(6):2667-75. PubMed ID: 8675633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced synthesis and accumulation of proteoglycans in cholesterol-enriched arterial smooth muscle cells.
    Vijayagopal P
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):603-11. PubMed ID: 8373376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial heparan sulfate proteoglycan. I. Inhibitory effects on smooth muscle cell proliferation.
    Benitz WE; Kelley RT; Anderson CM; Lorant DE; Bernfield M
    Am J Respir Cell Mol Biol; 1990 Jan; 2(1):13-24. PubMed ID: 2137707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of vascular proteoglycan synthesis by metabolic factors associated with diabetes.
    Wilson P; Drennon K; Tannock LR
    J Investig Med; 2007 Jan; 55(1):18-25. PubMed ID: 17441408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs.
    Little PJ; Tannock L; Olin KL; Chait A; Wight TN
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):55-60. PubMed ID: 11788461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro.
    Björkerud S
    Arterioscler Thromb; 1991; 11(4):892-902. PubMed ID: 2065041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular smooth muscle cells from injured rat aortas display elevated matrix production associated with transforming growth factor-beta activity.
    Rasmussen LM; Wolf YG; Ruoslahti E
    Am J Pathol; 1995 Oct; 147(4):1041-8. PubMed ID: 7573349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta induces a chondroitin sulfate/dermatan sulfate proteoglycan in alveolar type II cells.
    Maniscalco WM; Campbell MH
    Am J Physiol; 1994 Jun; 266(6 Pt 1):L672-80. PubMed ID: 8023956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor-[beta] type I receptor.
    Little PJ; Burch ML; Getachew R; Al-aryahi S; Osman N
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):360-8. PubMed ID: 20625315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.